← Back
$NKTR All transactions

NEKTAR THERAPEUTICS

▼ SELL 10b5-1 Plan

$ Value

$41K

Shares

1,134

Price

$36

Filed

Sep 8

Insider

Name

ROBIN HOWARD W

Title

President & CEO

CIK

0001206869

Roles

Director Officer

Transaction Details

Transaction Date

2025-09-04

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

62,674

Footnotes

This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. | This transaction was executed in multiple trades at prices ranging from $32.01 to $32.99 The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer. | This transaction was executed in multiple trades at prices ranging from $33.02 to $33.99. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer. | This transaction was executed in multiple trades at prices ranging from $34.05 to $34.99. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer. | This transaction was executed in multiple trades at prices ranging from $35.35 to $36.11. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer. | This transaction was executed in multiple trades at prices ranging from $37.50 to $38.26. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer. | This transaction was executed in multiple trades at prices ranging from $38.50 to $39.37. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer. | This transaction was executed in multiple trades at prices ranging from $39.50 to $40.32. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.

Filing Info

Accession No.

0000950170-25-113691

Form Type

4

Issuer CIK

0000906709

ROBIN HOWARD W's History

Date Ticker Type Value
2026-02-18 NKTR $31K
2025-12-22 NKTR A $0
2025-12-22 NKTR A $0
2025-11-25 NKTR $120K
2025-11-21 NKTR A $0
2025-11-21 NKTR A $0
2025-09-09 NKTR $95K
2025-09-09 NKTR $56K
2025-09-09 NKTR $102K
2025-09-09 NKTR $58K

Other Insiders at NKTR (90d)

Insider Bought Sold Last
ROBIN HOWARD W
President & CEO
$31K 2026-02-18
Zalevsky Jonathan
Chief R&D Officer
$13K 2026-02-18